Christian Récher
Centre National de la Recherche Scientifique(FR)Université Toulouse III - Paul Sabatier(FR)Université Toulouse III - Paul Sabatier(FR)Université de Bordeaux(FR)Inserm(FR)Université Fédérale de Toulouse Midi-Pyrénées(FR)Institut Gustave Roussy(FR)Saint Louis University Hospital(US)Centre Hospitalier Universitaire de Bordeaux(FR)Centre Hospitalier Universitaire de Toulouse(FR)Centre de Recherche en Cancérologie de Toulouse(FR)La Ligue Contre le Cancer(FR)Institut universitaire du cancer de Toulouse Oncopole(FR)Toulouse Mathematics Institute(FR)ideXlab (France)(FR)The Cancer Institute Hospital(JP)Centre de Recherche en Cancérologie de Marseille(FR)Institut Paoli-Calmettes(FR)BoRdeaux Institute of onCology(FR)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Cancer, Lipids, and Metabolism, Ferroptosis and cancer prognosis, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML(2019)1,191 cited
- → International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts(2015)1,137 cited
- → Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism(2017)895 cited
- → Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials(2014)681 cited
- → High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis(2007)514 cited
- → Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure(2011)476 cited